Olstein Capital Management L.P. reduced its stake in shares of Xylem Inc. (NYSE:XYL) by 2.8% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 69,000 shares of the company’s stock after selling 2,000 shares during the period. Olstein Capital Management L.P.’s holdings in Xylem were worth $3,619,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of XYL. Seven Eight Capital LLC boosted its position in Xylem by 1,976.2% in the first quarter. Seven Eight Capital LLC now owns 8,720 shares of the company’s stock valued at $357,000 after buying an additional 8,300 shares during the period. Euclid Advisors LLC boosted its position in Xylem by 23.1% in the first quarter. Euclid Advisors LLC now owns 43,035 shares of the company’s stock valued at $1,760,000 after buying an additional 8,085 shares during the period. First Republic Investment Management Inc. boosted its position in Xylem by 5.2% in the first quarter. First Republic Investment Management Inc. now owns 29,257 shares of the company’s stock valued at $1,197,000 after buying an additional 1,459 shares during the period. BlueMountain Capital Management LLC acquired a new position in Xylem during the first quarter valued at approximately $180,000. Finally, Boothbay Fund Management LLC acquired a new position in Xylem during the first quarter valued at approximately $350,000. 86.38% of the stock is owned by institutional investors.

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Shares of Xylem Inc. (NYSE:XYL) traded down 0.58% on Tuesday, hitting $51.34. The stock had a trading volume of 1,634,227 shares. The company has a market cap of $9.21 billion, a price-to-earnings ratio of 28.49 and a beta of 1.18. Xylem Inc. has a 52 week low of $31.67 and a 52 week high of $54.99. The firm has a 50 day moving average price of $50.32 and a 200-day moving average price of $48.42.

Xylem (NYSE:XYL) last released its quarterly earnings data on Tuesday, November 1st. The company reported $0.54 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.53 by $0.01. Xylem had a return on equity of 16.38% and a net margin of 8.83%. The company earned $897 million during the quarter, compared to analysts’ expectations of $913.53 million. During the same period last year, the firm posted $0.49 earnings per share. The business’s revenue was down .6% on a year-over-year basis. Analysts anticipate that Xylem Inc. will post $2.04 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 7th. Stockholders of record on Wednesday, November 9th will be given a $0.1549 dividend. The ex-dividend date is Monday, November 7th. This represents a $0.62 dividend on an annualized basis and a dividend yield of 1.21%. Xylem’s payout ratio is 34.44%.

COPYRIGHT VIOLATION NOTICE: This story was first posted by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are reading this story on another domain, it was stolen and reposted in violation of U.S. & international copyright & trademark law. The correct version of this story can be accessed at https://www.thecerbatgem.com/2016/11/29/olstein-capital-management-l-p-sells-2000-shares-of-xylem-inc-xyl.html.

Several equities analysts have recently commented on XYL shares. Royal Bank Of Canada increased their target price on Xylem from $47.00 to $51.00 and gave the company an “outperform” rating in a research note on Tuesday, August 16th. RBC Capital Markets set a $51.00 price objective on Xylem and gave the stock a “buy” rating in a research note on Tuesday, August 16th. Canaccord Genuity restated a “hold” rating and set a $50.00 price objective (up from $45.00) on shares of Xylem in a research note on Tuesday, August 16th. Atlantic Securities upgraded Xylem from a “neutral” rating to an “overweight” rating and set a $54.00 price objective on the stock in a research note on Monday, August 22nd. Finally, Janney Montgomery Scott upgraded Xylem from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $50.00 to $52.00 in a research note on Wednesday, November 2nd. Eight research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Xylem has a consensus rating of “Buy” and a consensus price target of $47.15.

In other news, SVP Claudia S. Toussaint sold 5,300 shares of the stock in a transaction that occurred on Friday, November 4th. The stock was sold at an average price of $47.27, for a total transaction of $250,531.00. Following the transaction, the senior vice president now owns 44,033 shares in the company, valued at $2,081,439.91. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Colin R. Sabol sold 27,473 shares of the stock in a transaction that occurred on Thursday, September 8th. The stock was sold at an average price of $50.91, for a total value of $1,398,650.43. Following the transaction, the insider now owns 65,530 shares in the company, valued at approximately $3,336,132.30. The disclosure for this sale can be found here. 0.77% of the stock is owned by insiders.

Xylem Company Profile

Xylem Inc is engaged in the design, manufacturing, and application of engineered technologies for the water industry. The Company is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

5 Day Chart for NYSE:XYL

Receive News & Stock Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related stocks with our FREE daily email newsletter.